148 related articles for article (PubMed ID: 8071703)
1. Relationship between in vitro transendothelial permeability and in vivo single-pass brain extraction.
Pirro JP; Di Rocco RJ; Narra RK; Nunn AD
J Nucl Med; 1994 Sep; 35(9):1514-9. PubMed ID: 8071703
[TBL] [Abstract][Full Text] [Related]
2. In vitro models for the blood-brain barrier.
Garberg P; Ball M; Borg N; Cecchelli R; Fenart L; Hurst RD; Lindmark T; Mabondzo A; Nilsson JE; Raub TJ; Stanimirovic D; Terasaki T; Oberg JO; Osterberg T
Toxicol In Vitro; 2005 Apr; 19(3):299-334. PubMed ID: 15713540
[TBL] [Abstract][Full Text] [Related]
3. Porcine brain microvessel endothelial cells as an in vitro model to predict in vivo blood-brain barrier permeability.
Zhang Y; Li CS; Ye Y; Johnson K; Poe J; Johnson S; Bobrowski W; Garrido R; Madhu C
Drug Metab Dispos; 2006 Nov; 34(11):1935-43. PubMed ID: 16896068
[TBL] [Abstract][Full Text] [Related]
4. Myocardial extraction of teboroxime: effects of teboroxime interaction with blood.
Rumsey WL; Rosenspire KC; Nunn AD
J Nucl Med; 1992 Jan; 33(1):94-101. PubMed ID: 1530970
[TBL] [Abstract][Full Text] [Related]
5. Brain extraction and distribution of 99mTc-bicisate in humans and in rats.
Knudsen GM; Andersen AR; Somnier FE; Videbaek C; Hasselbalch S; Paulson OB
J Cereb Blood Flow Metab; 1994 Jan; 14 Suppl 1():S12-8. PubMed ID: 8263066
[TBL] [Abstract][Full Text] [Related]
6. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes.
Nakagawa S; Deli MA; Kawaguchi H; Shimizudani T; Shimono T; Kittel A; Tanaka K; Niwa M
Neurochem Int; 2009; 54(3-4):253-63. PubMed ID: 19111869
[TBL] [Abstract][Full Text] [Related]
7. Side by side comparison between dynamic versus static models of blood-brain barrier in vitro: a permeability study.
Santaguida S; Janigro D; Hossain M; Oby E; Rapp E; Cucullo L
Brain Res; 2006 Sep; 1109(1):1-13. PubMed ID: 16857178
[TBL] [Abstract][Full Text] [Related]
8. Comparison of in vitro and in vivo models of drug transcytosis through the blood-brain barrier.
Pardridge WM; Triguero D; Yang J; Cancilla PA
J Pharmacol Exp Ther; 1990 May; 253(2):884-91. PubMed ID: 2338660
[TBL] [Abstract][Full Text] [Related]
9. Highly purified lipoteichoic acid from gram-positive bacteria induces in vitro blood-brain barrier disruption through glia activation: role of pro-inflammatory cytokines and nitric oxide.
Boveri M; Kinsner A; Berezowski V; Lenfant AM; Draing C; Cecchelli R; Dehouck MP; Hartung T; Prieto P; Bal-Price A
Neuroscience; 2006; 137(4):1193-209. PubMed ID: 16343789
[TBL] [Abstract][Full Text] [Related]
10. How well can in vitro brain microcapillary endothelial cell models predict rodent in vivo blood-brain barrier permeability?
Avdeef A
Eur J Pharm Sci; 2011 Jun; 43(3):109-24. PubMed ID: 21514381
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of alkylated derivatives of 99mTc-propylene amine oxime (99mTc-PnAO).
Hoffman TJ; Volkert WA; Corlija M; McKenzie EH; Chaplin SB; Oberle PA; Holmes RA
J Nucl Biol Med (1991); 1992; 36(1):46-51. PubMed ID: 1450225
[TBL] [Abstract][Full Text] [Related]
12. A functional in vitro model of rat blood-brain barrier for molecular analysis of efflux transporters.
Perrière N; Yousif S; Cazaubon S; Chaverot N; Bourasset F; Cisternino S; Declèves X; Hori S; Terasaki T; Deli M; Scherrmann JM; Temsamani J; Roux F; Couraud PO
Brain Res; 2007 May; 1150():1-13. PubMed ID: 17434463
[TBL] [Abstract][Full Text] [Related]
13. Development of a humanized in vitro blood-brain barrier model to screen for brain penetration of antiepileptic drugs.
Cucullo L; Hossain M; Rapp E; Manders T; Marchi N; Janigro D
Epilepsia; 2007 Mar; 48(3):505-16. PubMed ID: 17326793
[TBL] [Abstract][Full Text] [Related]
14. Influence of basolateral condition on the regulation of brain microvascular endothelial tight junction properties and barrier function.
Colgan OC; Collins NT; Ferguson G; Murphy RP; Birney YA; Cahill PA; Cummins PM
Brain Res; 2008 Feb; 1193():84-92. PubMed ID: 18177846
[TBL] [Abstract][Full Text] [Related]
15. Studies of the retention mechanism of the brain perfusion imaging agent 99mTc-bicisate (99mTc-ECD).
Walovitch RC; Cheesman EH; Maheu LJ; Hall KM
J Cereb Blood Flow Metab; 1994 Jan; 14 Suppl 1():S4-11. PubMed ID: 8263070
[TBL] [Abstract][Full Text] [Related]
16. Functional characterization and comparison of the outer blood-retina barrier and the blood-brain barrier.
Steuer H; Jaworski A; Elger B; Kaussmann M; Keldenich J; Schneider H; Stoll D; Schlosshauer B
Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):1047-53. PubMed ID: 15728564
[TBL] [Abstract][Full Text] [Related]
17. Characterization of an "in vitro" blood-brain barrier: effects of molecular size and lipophilicity on cerebrovascular endothelial transport rates of drugs.
van Bree JB; de Boer AG; Danhof M; Ginsel LA; Breimer DD
J Pharmacol Exp Ther; 1988 Dec; 247(3):1233-9. PubMed ID: 3204515
[TBL] [Abstract][Full Text] [Related]
18. Immortalized human brain endothelial cells and flow-based vascular modeling: a marriage of convenience for rational neurovascular studies.
Cucullo L; Couraud PO; Weksler B; Romero IA; Hossain M; Rapp E; Janigro D
J Cereb Blood Flow Metab; 2008 Feb; 28(2):312-28. PubMed ID: 17609686
[TBL] [Abstract][Full Text] [Related]
19. Impaired induction of blood-brain barrier properties in aortic endothelial cells by astrocytes from GFAP-deficient mice.
Pekny M; Stanness KA; Eliasson C; Betsholtz C; Janigro D
Glia; 1998 Apr; 22(4):390-400. PubMed ID: 9517571
[TBL] [Abstract][Full Text] [Related]
20. Development of an in vitro blood-brain barrier model to study molecular neuropathogenesis and neurovirologic disorders induced by human immunodeficiency virus type 1 infection.
Mukhtar M; Pomerantz RJ
J Hum Virol; 2000; 3(6):324-34. PubMed ID: 11100913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
